Medicina
Facultad
Kyoto University
Kioto, JapónPublicaciones en colaboración con investigadores/as de Kyoto University (46)
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial
The Lancet Oncology, Vol. 24, Núm. 1, pp. 77-90
-
Author Correction: Optical coherence tomography in coronary atherosclerosis assessment and intervention (Nature Reviews Cardiology, (2022), 19, 10, (684-703), 10.1038/s41569-022-00687-9)
Nature Reviews Cardiology
-
Country-level gender inequality is associated with structural differences in the brains of women and men
Proceedings of the National Academy of Sciences of the United States of America, Vol. 120, Núm. 20
-
Machine learning to predict major bleeding during anticoagulation for venous thromboembolism: possibilities and limitations
British Journal of Haematology, Vol. 201, Núm. 5, pp. 971-981
2022
-
Cost-effectiveness of palbociclib in early breast cancer patients with a high risk of relapse: Results from the PENELOPE-B trial
Frontiers in Oncology, Vol. 12
-
Effects of capecitabine as part of neo-/adjuvant chemotherapy – A meta-analysis of individual breast cancer patient data from 13 randomised trials including 15,993 patients
European Journal of Cancer, Vol. 166, pp. 185-201
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
-
Optical coherence tomography in coronary atherosclerosis assessment and intervention
Nature Reviews Cardiology, Vol. 19, Núm. 10, pp. 684-703
-
Racial and ethnic differences in pharmacotherapy to prevent coronary artery disease and thrombotic events
European heart journal. Cardiovascular pharmacotherapy, Vol. 8, Núm. 7, pp. 738-751
2021
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight
eLife, Vol. 10
-
Palbociclib for Residual High-Risk Invasive HR-Positive and HER2-Negative Early Breast Cancer-The Penelope-B Trial
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 39, Núm. 14, pp. 1518-1530
-
Spontaneous ARIA-like events in cerebral amyloid angiopathy–related inflammation a multicenter prospective longitudinal cohort study
Neurology, Vol. 97, Núm. 18, pp. E1809-E1822
-
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
npj Breast Cancer, Vol. 7, Núm. 1
2020
-
Derivation and validation of a clinical prediction rule for thrombolysis-associated major bleeding in patients with acute pulmonary embolism: The BACS score
European Respiratory Journal, Vol. 56, Núm. 6
-
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial
The Lancet Oncology, Vol. 21, Núm. 12, pp. 1574-1588
-
Health-Related Quality of Life in MONARCH 3: Abemaciclib plus an Aromatase Inhibitor as Initial Therapy in HR+, HER2− Advanced Breast Cancer
Oncologist, Vol. 25, Núm. 9, pp. e1346-e1354
-
β-Catenin Role in the Vulnerability/Resilience to Stress-Related Disorders Is Associated to Changes in the Serotonergic System
Molecular Neurobiology, Vol. 57, Núm. 3, pp. 1704-1715